|Title of Law:||Children's Health Act of 2000|
|Law #:||Public Law 106-310|
|Passed by Congress:||106th Congress (2nd Session)|
The following are excerpts, highlighted in red, from the final legislation and/or conference report which contain National Academies' studies. (Pound signs [##] between passages denote the deletion of unrelated text.)
HR4365 Bilirakis (R-Fla.) 09/27/00
Enrolled (finally passed both houses)
To amend the Public Health Service Act with respect to childrenīs health.
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
TITLE XXI-SPECIAL NEEDS OF CHILDREN REGARDING ORGAN TRANSPLANTATION
SEC. 2101. ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK; AMENDMENTS REGARDING NEEDS OF CHILDREN.
(a) IN GENERAL.-Section 372(b)(2) of the Public Health Service Act (42 U.S.C. 274(b)(2)) is amended-
(1) in subparagraph (J), by striking "and" at the end;
(2) in each of subparagraphs (K) and (L), by striking the period and inserting a comma; and
(3) by adding at the end the following subparagraphs:
"(M) recognize the differences in health and in organ transplantation issues between children and adults throughout the system and adopt criteria, polices, and procedures that address the unique health care needs of children,
"(N) carry out studies and demonstration projects for the purpose of improving procedures for organ donation procurement and allocation, including but not limited to projects to examine and attempt to increase transplantation among populations with special needs, including children and individuals who are members of racial or ethnic minority groups, and among populations with limited access to transportation, and
"(O) provide that for purposes of this paragraph, the term `childrenī refers to individuals who are under the age of 18.".
(b) STUDY REGARDING IMMUNOSUPPRESSIVE DRUGS.-
(1) IN GENERAL.-The Secretary of Health and Human Services (referred to in this subsection as the "Secretary") shall provide for a study to determine the costs of immunosuppressive drugs that are provided to children pursuant to organ transplants and to determine the extent to which health plans and health insurance cover such costs. The Secretary may carry out the study directly or through a grant to the Institute of Medicine (or other public or nonprofit private entity).
(2) RECOMMENDATIONS REGARDING CERTAIN ISSUES.-The Secretary shall ensure that, in addition to making determinations under paragraph (1), the study under such paragraph makes recommendations regarding the following issues:
(A) The costs of immunosuppressive drugs that are provided to children pursuant to organ transplants and to determine the extent to which health plans, health insurance and government programs cover such costs.
(B) The extent of denial of organs to be released for transplant by coroners and medical examiners.
(C) The special growth and developmental issues that children have pre- and post-organ transplantation.
(D) Other issues that are particular to the special health and transplantation needs of children.
(3) REPORT.-The Secretary shall ensure that, not later than December 31, 2001, the study under paragraph (1) is completed and a report describing the findings of the study is submitted to the Congress.
TITLE XXVIII-MISCELLANEOUS PROVISIONS
SEC. 2801. REPORT REGARDING RESEARCH ON RARE DISEASES IN CHILDREN.
Not later than 180 days after the date of the enactment of this Act, the Director of the National Institutes of Health shall submit to the Congress a report on-
(1) the activities that, during fiscal year 2000, were conducted and supported by such Institutes with respect to rare diseases in children, including Friedreichīs ataxia and Hutchinson-Gilford progeria syndrome; and
(2) the activities that are planned to be conducted and supported by such Institutes with respect to such diseases during the fiscal years 2001 through 2005.
SEC. 2802. STUDY ON METABOLIC DISORDERS.
(a) IN GENERAL.-The Secretary of Health and Human Services (in this section referred to as the "Secretary") shall, in consultation with relevant experts or through the Institute of Medicine, study issues related to treatment of PKU and other metabolic disorders for children, adolescents, and adults, and mechanisms to assure access to effective treatment, including special diets, for children and others with PKU and other metabolic disorders. Such mechanisms shall be evidence-based and reflect the best scientific knowledge regarding effective treatment and prevention of disease progression.
(b) DISSEMINATION OF RESULTS.-Upon completion of the study referred to in subsection (a), the Secretary shall disseminate and otherwise make available the results of the study to interested groups and organizations, including insurance commissioners, employers, private insurers, health care professionals, State and local public health agencies, and State agencies that carry out the Medicaid program under title XIX of the Social Security Act or the State childrenīs health insurance program under title XXI of such Act.
(c) AUTHORIZATION OF APPROPRIATIONS.-There are authorized to be appropriated to carry out this section such sums as may be necessary for each of the fiscal years 2001 through 2003.
PART III-ABUSE PREVENTION AND TREATMENT
SEC. 3632. METHAMPHETAMINE AND AMPHETAMINE TREATMENT INITIATIVE BY CENTER FOR SUBSTANCE ABUSE TREATMENT.
Subpart 1 of part B of title V of the Public Health Service Act (42 U.S.C. 290bb et seq.) is amended by adding at the end the following new section:
"methamphetamine and amphetamine treatment initiative
"SEC. 514. (a) GRANTS.-
"(1) AUTHORITY TO MAKE GRANTS.-The Director of the Center for Substance Abuse Treatment may make grants to States and Indian tribes recognized by the United States that have a high rate, or have had a rapid increase, in methamphetamine or amphetamine abuse or addiction in order to permit such States and Indian tribes to expand activities in connection with the treatment of methamphetamine or amphetamine abuser or addiction in the specific geographical areas of such States or Indian tribes, as the case may be, where there is such a rate or has been such an increase.
"(2) RECIPIENTS.-Any grants under paragraph (1) shall be directed to the substance abuse directors of the States, and of the appropriate tribal government authorities of the Indian tribes, selected by the Director to receive such grants.
"(3) NATURE OF ACTIVITIES.-Any activities under a grant under paragraph (1) shall be based on reliable scientific evidence of their efficacy in the treatment of methamphetamine or amphetamine abuse or addiction.
"(b) GEOGRAPHIC DISTRIBUTION.-The Director shall ensure that grants under subsection (a) are distributed equitably among the various regions of the country and among rural, urban, and suburban areas that are affected by methamphetamine or amphetamine abuse or addiction.
"(c) ADDITIONAL ACTIVITIES.-The Director shall-
"(1) evaluate the activities supported by grants under subsection (a);
"(2) disseminate widely such significant information derived from the evaluation as the Director considers appropriate to assist States, Indian tribes, and private providers of treatment services for methamphetamine or amphetamine abuser or addiction in the treatment of methamphetamine or amphetamine abuse or addiction; and
"(3) provide States, Indian tribes, and such providers with technical assistance in connection with the provision of such treatment.
"(d) AUTHORIZATION OF APPROPRIATIONS.-
"(1) IN GENERAL.-There are authorized to be appropriated to carry out this section $10,000,000 for fiscal year 2000 and such sums as may be necessary for each of fiscal years 2001 and 2002.
"(2) USE OF CERTAIN FUNDS.-Of the funds appropriated to carry out this section in any fiscal year, the lesser of 5 percent of such funds or $1,000,000 shall be available to the Director for purposes of carrying out subsection (c).".
SEC. 3633. STUDY OF METHAMPHETAMINE TREATMENT.
(1) REQUIREMENT.-The Secretary of Health and Human Services shall, in consultation with the Institute of Medicine of the National Academy of Sciences, conduct a study on the development of medications for the treatment of addiction to amphetamine and methamphetamine.
(2) REPORT.-Not later than 9 months after the date of the enactment of this Act, the Secretary shall submit to the Committees on the Judiciary of the Senate and House of Representatives a report on the results of the study conducted under paragraph (1).
(b) AUTHORIZATION OF APPROPRIATIONS.-There are hereby authorized to be appropriated for the Department of Health and Human Services for fiscal year 2000 such sums as may be necessary to meet the requirements of subsection (a).
SEC. 3641. REPORTS ON CONSUMPTION OF METHAMPHETAMINE AND OTHER ILLICIT DRUGS IN RURAL AREAS, METROPOLITAN AREAS, AND CONSOLIDATED METROPOLITAN AREAS.
The Secretary of Health and Human Services shall include in each National Household Survey on Drug Abuse appropriate prevalence data and information on the consumption of methamphetamine and other illicit drugs in rural areas, metropolitan areas, and consolidated metropolitan areas.